Who is sponsoring NCT03161886?

NCT03161886 is sponsored by Azienda Policlinico Umberto I.

What drugs are being tested in NCT03161886?

Interventions in NCT03161886: Pan-enteric Capsule Endoscopy (PCE).

What condition does NCT03161886 study?

NCT03161886 studies Inflammatory Bowel Diseases, Children, Only.

Is NCT03161886 still recruiting?

NCT03161886 is currently completed. Last updated 8 January 2018.

Last reviewed 2018-01-08 · How we verify

NCT03161886: PCE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Treat-to-target Strategy Using Pan-enteric Capsule Endoscopy (PCE) in Paediatric Crohn's Disease (CD).

Completed NA Last updated 8 January 2018

What this trial tests

NA trial testing Pan-enteric Capsule Endoscopy (PCE) in Inflammatory Bowel Diseases in 48 participants. Completed in 10 January 2017.

Timeline

1 December 2014

Primary endpoint
1 December 2016

10 January 2017

Quick facts

Lead sponsor	Azienda Policlinico Umberto I
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	48
Start date	1 December 2014
Primary completion	1 December 2016
Estimated completion	10 January 2017

Drugs / interventions tested

Pan-enteric Capsule Endoscopy (PCE)

Conditions studied

Inflammatory Bowel Diseases — all drugs for Inflammatory Bowel Diseases →
Children, Only — all drugs for Children, Only →

Sponsor

Azienda Policlinico Umberto I

Who can join

Adults 6 to 18, any sex, with Inflammatory Bowel Diseases or Children, Only. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective, interventional study aims this to determine the efficacy and safety of a PCE-based treat-to-target strategy in order to achieve Mucosal Healing (MH) and deep remission (DR) of pediatric Crohn's Disease (CD) over 52 weeks.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

A Treat to Target Strategy Using Panenteric Capsule Endoscopy in Pediatric Patients With Crohn's Disease.
Oliva S, Aloi M, Viola F, Mallardo S, et al · · 2019 · cited 42× · PMID 30326301 · DOI 10.1016/j.cgh.2018.10.015
A Treat-to-Target Strategy Guided by Pan-Enteric Evaluation in Children With Crohn's Disease Improves Outcomes at 2 Years.
D'Arcangelo G, Russo G, Aloi M, Ruggiero C, et al · · 2024 · cited 1× · PMID 37603835 · DOI 10.1093/ibd/izad173

Verify or expand the search:

Other recruiting trials for Inflammatory Bowel Diseases

Currently open trials in the same condition.

NCT07520747 — A Database Study of Disease, Treatment Patterns and Healthcare Use in Children With Inflammatory Bowel Diseases in Korea · recruiting
NCT07349472 — Pentoxifylline in Patients With Ulcerative Colitis · Phase 2 · recruiting
NCT07033208 — Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance · NA · recruiting
NCT06842316 — Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases · recruiting
NCT06453317 — Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis · Phase 2 · recruiting

Other Azienda Policlinico Umberto I trials

Trials by the same sponsor.

NCT06752135 — Node Positive Cervical Cancer Treated by Neoadjuvant Chemotherapy Plus Radical Surgery: a Single Center Experience · terminated
NCT06770894 — DPP4-Inhibitors and Bone Metabolism in Diabetes · Phase 3 · completed
NCT03579485 — An Observational Retrospective Database Analysis to Evaluate Raltegravir Based-regimens, Including NUC-sparing Regimens, · unknown
NCT03875417 — Multidisciplinary Management of HCC in Elderly Patients · completed
NCT03670992 — Surgical Treatment of Pancreatic RCC Metastases · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03161886 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Azienda Policlinico Umberto I
Last refreshed: 8 January 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03161886.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing